NVS Novartis AG Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

NVS [NYSE]

Novartis AG

Healthcare | Drug Manufacturers - General | Switzerland

statements

Index	-	P/E	27.20	EPS (ttm)	3.23	Insider Own	9.30%	Shs Outstand	2.28B	Perf Week	-1.07%
Market Cap	222.13B	Forward P/E	14.22	EPS next Y	6.18	Insider Trans	0.00%	Shs Float	2.14B	Perf Month	1.61%
Income	7.45B	PEG	3.96	EPS next Q	1.37	Inst Own	10.90%	Short Float	0.12%	Perf Quarter	8.55%
Sales	49.93B	P/S	4.45	EPS this Y	-43.60%	Inst Trans	-2.14%	Short Ratio	1.31	Perf Half Y	-7.22%
Book/sh	22.37	P/B	3.93	EPS next Y	10.50%	ROA	10.30%	Target Price	104.00	Perf Year	-4.61%
Cash/sh	1.97	P/C	44.67	EPS next 5Y	6.88%	ROE	23.10%	52W Range	69.18 - 99.84	Perf YTD	-7.22%
Dividend	3.09	P/FCF	37.53	EPS past 5Y	-6.50%	ROI	8.60%	52W High	-12.01%	Beta	0.54
Dividend %	3.52%	Quick Ratio	0.50	Sales past 5Y	-1.90%	Gross Margin	71.30%	52W Low	26.99%	ATR	1.66
Employees	109000	Current Ratio	0.70	Sales Q/Q	11.50%	Oper. Margin	19.20%	RSI (14)	52.33	Volatility	1.61% 1.50%
Optionable	Yes	Debt/Eq	0.72	EPS Q/Q	18.90%	Profit Margin	24.30%	Rel Volume	0.60	Prev Close	87.34
Shortable	Yes	LT Debt/Eq	0.50	Earnings	Apr 28 BMO	Payout	53.50%	Avg Volume	1.96M	Price	87.85
Recom	1.00	SMA20	0.34%	SMA50	1.51%	SMA200	-0.54%	Volume	1,200,781	Change	0.58%

Jun-15-20

Upgrade

Citigroup

Neutral → Buy

Mar-10-20

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Feb-25-20

Downgrade

Guggenheim

Buy → Neutral

Apr-25-19

Upgrade

Liberum

Hold → Buy

Apr-25-19

Upgrade

Guggenheim

Neutral → Buy

Apr-10-19

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jan-02-19

Downgrade

JP Morgan

Neutral → Underweight

Dec-11-18

Resumed

Jefferies

Buy

Oct-09-18

Initiated

Guggenheim

Neutral

Sep-10-18

Upgrade

BofA/Merrill

Underperform → Buy

May-29-18

Downgrade

HSBC Securities

Buy → Hold

May-25-18

Upgrade

Credit Suisse

Underperform → Neutral

Jan-25-18

Reiterated

Leerink Partners

Outperform

$93 → $100

Dec-06-17

Downgrade

BofA/Merrill

Neutral → Underperform

Jul-26-17

Upgrade

Morgan Stanley

Underweight → Overweight

Jul-05-17

Downgrade

Credit Suisse

Neutral → Underperform

Mar-09-17

Initiated

Liberum

Buy

Mar-08-17

Upgrade

Societe Generale

Hold → Buy

Mar-07-17

Downgrade

Exane BNP Paribas

Neutral → Underperform

Jan-11-17

Downgrade

Credit Suisse

Outperform → Neutral

Jul-01-20 10:40PM	Novartis pays $729 million to settle U.S. kickback charges Reuters
10:08PM	Stocks - Europe Seen Higher on Virus Vaccine Optimism Investing.com
06:35PM	Novartis pays $729 million to settle U.S. kickback charges Reuters
03:47PM	Amgen's Win, Netflix's Hire Send Nasdaq Higher Motley Fool
10:42AM	Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise Reuters
Jun-30-20 11:00AM	NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm PR Newswire
Jun-29-20 04:34PM	Novartis Gets Positive CHMP View for Cosentyx Label Expansion Zacks
02:10PM	NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm ACCESSWIRE
02:06PM	Race for a COVID-19 vaccine has drug makers scaling up manufacturing before one is developed MarketWatch
07:47AM	These 6 health-care stocks are buys because they can thrive under either Trump or Biden MarketWatch
Jun-28-20 11:36PM	Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawal Reuters
02:23PM	The Week Ahead In Biotech (June 28- July 4): Pending Clinical Readouts In Focus During A Short Holiday Week Benzinga
Jun-26-20 07:32PM	EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG NVS Business Wire
08:21AM	How gene therapy and CRISPR are helping to cure blindness MarketWatch
07:34AM	Novartis faces key meeting in U.S. bribery scandal after settling corruption case Reuters
07:23AM	Novartis faces key meeting in U.S. bribery scandal after settling corruption case Reuters
Jun-25-20 11:30PM	ESG strategies still buoyant despite Covid, say in-house lawyers Financial Times
03:57PM	Novartis Settles DoJ and SEC Charges for $347 Million TheStreet.com
03:49PM	Novartis, Units Admit Violating Bribery Law Bashed by Trump Bloomberg
02:49PM	UPDATE: Swiss drug company Novartis settles with DoJ, SEC in case brought under Foreign Corrupt Practices Act MarketWatch
01:31PM	Novartis, former unit to pay $346 million to resolve U.S. bribery charges Reuters
05:57AM	European stocks inch higher after previous days pounding; Wirecard collapses MarketWatch
Jun-22-20 02:51PM	Novartis Discontinues HCQ Study Due to Enrollment Challenges Zacks
Jun-19-20 06:04PM	Alzheimer's Drug Approval More Critical for Biogen After Patent Decision GuruFocus.com
04:32PM	Nkarta files for IPO MarketWatch
07:25AM	Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs Zacks
Jun-18-20 05:53PM	PTC Announcement on Covid-19 Candidate Met With Investor Indifference GuruFocus.com
Jun-17-20 10:11AM	Lilly Stock Has a 10% Upside, Guggenheim Says Barrons.com
09:56AM	Novartis' (NVS) Cosentyx Gets FDA Nod for New Indication Zacks
07:30AM	The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked Benzinga
04:06AM	Novartis Scores FDA Ilaris Approval For Rare Type Of Arthritis SmarterAnalyst
Jun-16-20 10:49AM	Eli Lillys Cancer Drug Succeeded Where Pfizer Failed. What It Means for Their Stocks. Barrons.com
09:00AM	Is Amgen Stock A Buy As It Takes A Two-Pronged Approach To Coronavirus? Investor's Business Daily
Jun-15-20 02:49PM	Coronavirus update: US sees steady resurgence as FDA puts nail in coffin of hydroxychloroquine debate Yahoo Finance
Jun-12-20 10:16AM	Do Hedge Funds Love Novartis AG (NVS)? Insider Monkey
Jun-11-20 03:23PM	Novartis' (NVS) Beovu Gets FDA Approval for Label Update Zacks
11:37AM	AstraZeneca's R&D Spending Spikes 21% to Industry Best in 2019 GuruFocus.com
Jun-10-20 01:04PM	U.S. attorney general group sues 26 dermatology drug makers Reuters
12:58PM	U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit Reuters
Jun-09-20 04:28PM	Roche, Johnson & Johnson Top R&D Spenders in 2019 GuruFocus.com
10:31AM	The Zacks Analyst Blog Highlights: Mastercard, Novartis, Boeing Company, Sanofi and Honeywell International Zacks
Jun-08-20 12:29PM	Vertex CEO Provided Best Value for Investors GuruFocus.com
10:59AM	Top Stock Reports for Mastercard, Novartis & Boeing Zacks
Jun-05-20 12:48PM	Hope dims for hydroxychloroquine even as medical study detailing the drugs failure is retracted MarketWatch
10:21AM	Novartis' Asthma Treatment Meets Primary Endpoint in Phase III Zacks
09:09AM	Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals Zacks
07:34AM	The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid Benzinga
Jun-04-20 04:01PM	Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO GuruFocus.com
11:12AM	Novartis (NVS) Announces Positive Data From Cosentyx Study Zacks
08:13AM	The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic Benzinga
Jun-03-20 06:24PM	Pliant Therapeutics Up 33% on IPO Pricing Motley Fool
12:31PM	Novartis' sBLA for Ofatumumab Gets Extended Review From FDA Zacks
07:39AM	The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study Benzinga
Jun-02-20 10:53AM	AstraZeneca Ranked Most Inventive, Roche Most Innovative GuruFocus.com
Jun-01-20 10:05AM	Novartis' (NVS) Breast Cancer Drug Gets Positive CHMP Opinion Zacks
May-31-20 05:32PM	Bristol-Myers Deserves Better Than a Single-Digit Multiple GuruFocus.com
May-28-20 02:26PM	Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate Motley Fool
11:42AM	Coronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp up Yahoo Finance
10:26AM	Big Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & More Zacks
09:40AM	Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful Reuters
May-27-20 07:25AM	The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas Benzinga
03:59AM	Rising Swiss rivalry as Roche and Novartis target same diseases Reuters
May-22-20 07:46AM	Telehealth is going to 'become the default' for patients: Ro CEO Yahoo Finance
May-19-20 10:52AM	Novartis Gets EC Approval for Gene Therapy Zolgensma in SMA Zacks
10:13AM	Trump's hydroxychloroquine use underscores line between drug's promise and 'happy talk' Yahoo Finance
08:24AM	The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering Benzinga
May-18-20 12:22PM	Deciphera (DCPH) Secures Early FDA Nod for GIST Drug Qinlock Zacks
May-16-20 12:00AM	Drugmakers get hooked on data Financial Times
May-15-20 02:59AM	Novartis CEO says any new coronavirus vaccine will take two years: newspaper Reuters
May-14-20 11:51AM	Coronavirus Vaccine Progress Accelerates Yahoo Finance
02:43AM	Top 5 Things to Know in the Market on Thursday, May 14th Investing.com
May-12-20 05:45PM	Novartis Stock Shows Rising Relative Strength; Mostly V-Shape Recovery From Covid Crash Investor's Business Daily
May-08-20 11:04AM	Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY Zacks
May-07-20 07:41AM	The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 Benzinga
May-05-20 03:26PM	Coronavirus U.S. death toll may hit 134k+ by early August, study reveals Yahoo Finance Video
May-04-20 05:59PM	Cytokinetics Trading at Half High Target of $30 GuruFocus.com
03:50PM	Novartis AG (NVS): Were Hedge Funds Right About This Stock? Insider Monkey
03:25PM	Top Analyst Reports for Apple, Berkshire Hathaway & Pfizer Zacks
08:55AM	Should You Buy Global Blood Therapeutics Before This Week's Earnings? Motley Fool
May-01-20 07:54AM	The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO Benzinga
Apr-30-20 12:52PM	Incyte (INCY) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-29-20 11:00AM	Novartis International AG (NVS) Q1 2020 Earnings Call Transcript Motley Fool
10:05AM	Biotech Stocks Earnings Roster for Apr 30: AMGN, GILD & More Zacks
01:56AM	Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales Reuters
01:48AM	Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales Reuters
Apr-28-20 04:07PM	Novartis Stock Dives Alongside Pharma Peers Despite First-Quarter Beat Investor's Business Daily
02:10PM	Novartis Stock Dives Alongside Pharma Peers Despite First-Quarter Beat Investor's Business Daily
10:32AM	Novartis (NVS) Q1 Earnings and Revenues Surpass Estimates Zacks
08:51AM	The Zacks Analyst Blog Highlights: Intel, Novartis, Toyota Motor, Union Pacific and Biogen Zacks
03:36AM	Novartis CEO: We Feel We Can Maintain Full Year Guidance Bloomberg
01:24AM	Novartis sales, profits rise in first quarter on COVID-19 buying rush Reuters
Apr-27-20 01:05PM	Top Research Reports for Intel, Novartis & Toyota Zacks
10:43AM	Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS Zacks
Apr-24-20 02:22PM	Coronavirus update: US death toll tops 50K as Trump stirs debate over treatments, reopenings Yahoo Finance
09:10AM	Pharma Stock Roundup: Q1 Earnings of LLY, Coronavirus Update from PFE, NVS, AZN Zacks
06:35AM	Hydroxychloroquine sparks renewed controversy but clinical trials are pushing ahead MarketWatch
Apr-23-20 11:02AM	Factors Setting the Tone for Novartis' (NVS) Q1 Earnings Zacks
Apr-22-20 07:51AM	The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership Benzinga
Apr-21-20 12:47PM	Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings? Zacks
12:31PM	Why Earnings Season Could Be Great for Novartis (NVS) Zacks

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. Its Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, established, and cardiovascular, renal and metabolism medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has collaboration agreements with Pear Therapeutics; Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute; Science 37; Bill & Melinda Gates Foundation; Amgen; University of California, Berkeley; Bristol-Myers Squibb; Drugs for Neglected Diseases initiative (DNDi); TScan Therapeutics; and Dyno Therapeutics Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novartis Bioventures Ltd	10% Owner	Nov 12	Buy	12.00	250,000	3,000,000	3,543,067	Nov 12 04:15 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience